Pharmacology & ToxicologybioRxivPreprint
Broad-spectrum, patient-adaptable inhaled niclosamide-lysozyme particles are efficacious against coronaviruses in lethal murine infection models
A. D. Brunaugh, H. Seo, Z. Warnken…·H. D. C. Smyth
This paper develops an inhaled niclosamide-lysozyme formulation effective against coronaviruses in mice, showing potent in vitro and in vivo activity against MERS-CoV and SARS-CoV-2.
DOI 10.1101/2020.09.24.310490